Protein Phosphatases but not Reactive Oxygen Species Play Functional Role in Acute Amphetamine-Mediated Dopamine Release

Cell Biochemistry and Biophysics

Volumn 66, Issue 3, 2013, Pages 831-841

  Paszti Gere, Erzsebet ^a   Jakus, Judit ^b  

^a SZENT ISTVÁN UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

AMPH; Cantharidin; Dopamine efflux; N acetylcysteine; Phosphatase inhibition; ROS

Indexed keywords

RATTUS;

EID: 84880958291     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-013-9608-6     Document Type: Article

References (47)

1. Mortensen, O. V., & Amara, S. G. (2003). Dynamic regulation of the dopamine transporter. European Journal of Pharmacology, 479, 159-170.
2. - dependent neurotransmission transporters: Drugs, substrates, presynaptic receptors and signaling systems. Pharmacology & Therapeutics, 92, 21-55.
3. Riddle, E. L., Fleckenstein, A. E., & Hanson, G. R. (2006). Mechanisms of metamphetamine-induced dopaminergic neurotoxicity. AAPS Journal, 8(Suppl 2), E413-E418.
4. Frey, B. N., Valvassori, S. S., Gomes, K. M., Martins, M. R., Dal-Pizzol, F., Kapczinski, F., et al. (2006). Increased oxidative stress in submitochondrial particles after chronic amphetamine exposure. Brain Research, 1097, 224-229.
5. Battin, E. E., & Brumaghim, J. L. (2009). Antioxidant activity of sulfur and selenium: A review of reactive oxygen species scavenging, glutathione peroxidase, and metal-binding antioxidant mechanisms. Cell Biochemistry and Biophysics, 55(Suppl 1), 1-23.
6. Thomas, D. M., Dowgiert, J., Geddes, T. J., Francescutti-Verbeem, D., Liu, X., & Kuhn, D. M. (2004). Microgial activation is a pharmacologically specific marker for the neurotoxic amphetamines. Neuroscience Letters, 367, 349-354.
7. Graham, D. G., Tiffany, S. M., Bell, W. R., & Gutknecht, W. F. (1978). Autooxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine and related compounds toward C1300 neuroblastoma cells in vitro. Molecular Pharmacology, 14, 644-653.
8. Wolf, M. E., Xue, C. J., Li, Y., & Wavak, D. (2000). Amphetamine increases glutamate efflux in the rat ventral tegmental area by a mechanism involving glutamate transporters and reactive oxygen species. Journal of Neurochemistry, 75, 1634-1644.
9. Wan, F. J., Lin, H. C., Lin, Y. S., & Tseng, C. J. (2000). Intrastriatal infusion D-AMPH induces hydroxyl radical formation: Inhibition by MK-801 pretreatment. Neuropharmacology, 39, 419-426.
10. Wan, F. J., Tung, C. S., Shiah, I. S., & Lin, H. C. (2006). Effects of α-phenyl-N-tert-butyl nitrone and N-acetylcysteine on hydroxyl radical formation and dopamine depletion in the rat striatum produced by d-AMPH. European Neuropsyhopharmacology, 16, 147-153.
11. Brown, J. F., & Yamamoto, B. K. (2003). Effects of AMPH on mitochondrial function: role of free radical and oxidative stress. Pharmacology& Therapeutics, 99, 45-53.
12. Haystead, T. A. J., Sim, A. T. R., Carling, D., Honnor, R. C., Tsukitani, Y., Cohen, P., et al. (1989). Effects of the tumor promoter okadaic acid on intracellular protein phosphorylation and metabolism. Nature, 337, 78-81.
13. Cohen, P., & Cohen, P. T. W. (1989). Protein phosphatases come of age. Journal of Biological Chemistry, 264, 21435-21438.
14. Cohen, P. T. W. (1997). Novel protein serine/threonine phosphatases: Variety in the spice of life. Trends in Biochemical Sciences, 22, 245-251.
15. Goldberg, Y. (1999). Protein phosphatase 2A: Who shall regulate the regulator? Biochemical Pharmacology, 57, 321-328.
16. McCluskey, A., Sim, A. T. R., & Sakoff, J. A. (2002). Serine-threonine protein phosphatase inhibitors: Development of potential therapeutic strategies. Journal of Medicinal Chemistry, 45, 1151-1175.
17. Wishart, M. J., & Guan, L. L. (2005). Protein phosphatases. Encyclopedia of Life Science, doi: 10. 1038/npg. els. 0003472.
18. Honkanen, R. E. (2005). Serine/threonine protein phosphatase inhibitors with antitumor activity. Handbook of Experimental Pharmacology, 167, 295-317.
19. Xu, J., Tian, W., Ma, X., Guo, J., Shi, Q., Jin, Y., et al. (2011). The molecular mechanism underlying morphine-induced Akt activation: Roles of protein phosphatases and reactive oxygen species. Cell Biochemistry and Biophysics, 61(Suppl 2), 303-311.
20. Bugnon, O., Ofori, S., & Schorderet, M. (1995). Okadaic acid modulates exocytotic and transporter-dependent release of dopamine in bovine retina in vitro. Archives of Pharmacology, 351, 53-59.
21. Vaughan, R. A., Huff, R. A., Uhl, G. R., & Kuhar, M. J. (1997). Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes. The Journal of Biological Chemistry, 272, 15541-15546.
22. Foster, J. D., Pananusorn, B., & Vaughan, R. A. (2002). Dopamine transporters are phosphorylated on N-terminal serines in rat striatum. The Journal of Biological Chemistry, 277, 25178-25186.
23. Page, G., Peeters, M., Najimi, M., Maloteaux, J. M., & Hermans, E. (2001). Modulation of the neuronal dopamine transporter activity by the metabotropic glutamate receptor mGluR5 in rat striatal synaptosomes through phosphorylation mediated processes. Journal of Neurochemistry, 76, 1282-1290.
24. Copeland, B. J., Vogelsberg, V., Neff, N. H., & Hadjiconstantinou, M. (1996). Protein kinase C activators decrease dopamine uptake into striatal synaptosomes. Journal of Pharmacology and Experimental Therapeutics, 277, 1527-1532.
25. Chi, L., & Reith, M. E. A. (2003). Substrate-induced trafficking of the DA transporter in heterologously expressing cells and in rat striatal synaptosomal preparations. The Journal of Pharmacology and Experimental Therapeutics, 307(Suppl 2), 729-736.
26. Zhang, L., Coffey, L. L., & Reith, M. E. A. (1997). Regulation of the functional activity of the human dopamine transporter by protein kinase C. Biochemical Pharmacology, 53, 677-688.
27. max. Journal of Neurochemistry, 68, 225-232.
28. Foster, J. D., Pananusorn, B., Cervinski, M. A., Holden, H. E., & Vaughan, R. A. (2003). Dopamine transporters are dephosphorylated in striatal homogenates and in vitro by protein phosphatase 1. Molecular Brain Research, 110, 100-108.
29. Kantor, L., Keikilani Hewlett, G. H., Park, Y. H., Richardson-Burns, S. M., Mellon, M. J., & Gnegy, M. E. (2001). Protein kinase C and intracellular calcium are required for AMPH-mediated DA release via the norepinephrine transporter in undifferentiated PC12 cells. The Journal of Pharmacology and Experimental Therapeutics, 297(Suppl 3), 1016-1024.
30. Garthwaite, G., Hajos, F., & Garthwaite, J. (1992). Morphological response of endoplasmic reticulum in cerebellar Purkinje cells to calcium deprivation. Neuroscience, 48(Suppl 3), 681-688.
31. Johnson, L. A., Guptaroy, B., Lund, D., Shamban, S., & Gnegy, M. E. (2005). Regulation of AMPH-stimulated DA efflux by protein kinase C beta. The Journal of Biological Chemistry, 280, 10914-10919.
32. Kantor, L., & Gnegy, M. E. (1998). Protein kinase C inhibitors block AMPH-mediated DA release in rat striatal slices. Journal of Pharmacology and Experimental Therapeutics, 284, 592-598.
33. Cowell, R. M., Kantor, L., Hewlett, G. H., Frey, K. A., & Gnegy, M. E. (2000). DA transporter antagonists block phorbol ester-induced DA release and DA transporter phosphorylation in striatal synaptosomes. European Journal of Pharmacology, 389, 59-65.
34. Furman, C. A., Chen, R., Guptaroy, B., Zhang, M., Holz, R. W., & Gnegy, M. (2009). DA and AMPH rapidly increase DA transporter trafficking to the surface: Live-cell imaging using total internal reflection fluorescence microscopy. The Journal of Neuroscience, 29(Suppl 10), 3328-3336.
35. Gere-Pászti, E., & Jakus, J. (2009). The effect of N-acetylcysteine on amphetamine-mediated dopamine release in rat brain striatal slices by ion-pair reversed-phase high performance liquid chromatography. Biomedical Chromatography, 23(Suppl 6), 658-664.
36. Greene, L. A., & Tischler, A. S. (1976). Establishment of a noradrenergic clonal cell line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proceedings of the National Academy of Science, 73, 2424-2428.
37. Martinovich, G. G., Martinovich, I. V., Cherenkevich, S. N., & Sauer, H. (2010). Redox buffer capacity of the cell: Theoretical and experimental approach. Cell Biochemistry and Biophysics, 58(Suppl 2), 75-83.
38. 2 release from activated human leucocytes using a dihydroxyphenoxazine derivative. Journal of Immunological Methods, 202, 133-141.
39. Heffner, T. G., Hartman, J. A., & Seiden, L. S. (1980). A rapid method for the regional dissection of the rat brain. Pharmacology, Biochemistry and Behavior, 13, 453-456.
40. Bonisch, H. (1984). The transport of +amphetamine by the neuronal noradrenaline carrier. Archives of Pharmacology, 327, 267-272.
41. Lancelot, E., Revand, M. L., Boulu, R. G., Plotkine, M., & Callebert, J. (1998). A microdialysis study investigating the mechanism of hydroxyl radical formulation in rat striatum exposed to glutamate. Brain Research, 809, 294-296.
42. Ischiropoulos, H., Nelson, J., Duran, D., & Al-Mehdi, A. (1996). Reactions of nitric oxide and peroxynitrite with organic molecules and ferrihorseradish peroxidase: Interference with the determination of hydrogen peroxide. Free Radical Biology & Medicine, 20, 373-381.
43. Rota, C., Chignell, C. F., & Mason, R. P. (1999). Evidence for free radical formation during the oxidation of 2, 7-dichlorofluorescin to the fluorescent dye 2, 7-dichlorofluorescein by horseradish peroxidase: Possible implications for oxidatives stress measurements. Free Radical Biology & Medicine, 27(Suppl 7-8), 873-881.
44. Sipos, I., Tretter, L., & Adam-Vizi, V. (2003). Quantitative relationship between inhibition of respiratory complexes and formation of reactive oxygen species in isolated nerve terminal. Journal of Neurochemistry, 84, 112-118.
45. Sim, A. T. R. (1991). The regulation and function of protein phosphatases in the brain. Molecular Neurobiology, 5, 229-246.
46. Lum, H., Podolski, J. L., Gurnack, M. E., Schulz, I. T., Huang, F., & Holian, O. (2001). Protein phosphatase 2B inhibitor potentiates endothelial PKC activity and barrier dysfunction. AJP Lung Cellular and Molecular Physiology, 281, 546-555.
47. Fienberg, A. A., Hiroi, N., Mermelstein, P. G., Song, W. J., Snyder, G. L., Nishi, A., et al. (1998). DARPP-32: Regulator of the efficacy of dopaminergic neurotransmission. Science, 281, 838-842.